Open access · CC-BY
via OpenAlex
Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease
Makis Tzioras, C. Davies, A. Newman, Rosemary J. Jackson, Tara L. Spires‐Jones
Neuropathology and Applied Neurobiology · 2018 · ▲ 147 citations
Abstract
Despite more than a century of research, the aetiology of sporadic Alzheimer's disease (AD) remains unclear and finding disease modifying treatments for AD presents one of the biggest medical challenges of our time. AD pathology is characterized by deposits of aggregated amyloid beta (Aβ) in amyloid plaques and aggregated tau in neurofibrillary tangles. These aggregates begin in distinct brain regions and spread throughout the brain in stereotypical patterns. Neurodegeneration, comprising loss of synapses and neurons, occurs in brain regions with high tangle pathology, and an inflammatory response of glial cells appears in brain regions with pathological aggregates. Inheriting an apolipoprotein E ε4 (APOE4) allele strongly increases the risk of developing AD for reasons that are not yet entirely clear. Substantial amounts of evidence support a role for APOE in modulating the aggregation and clearance of Aβ, and data have been accumulating recently implicating APOE4 in exacerbating neurodegeneration, tau pathology and inflammation. We hypothesize that APOE4 influences all the pathological hallmarks of AD and may sit at the interface between neurodegeneration, inflammation and the spread of pathologies through the brain. Here, we conducted a systematic search of the literature and review evidence supporting a role for APOE4 in neurodegeneration and inflammation. While there is no direct evidence yet for APOE4 influencing the spread of pathology, we postulate that this may be found in future based on the literature reviewed here. In conclusion, this review highlights the importance of understanding the role of APOE in multiple important pathological mechanisms in AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/nan.12529
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Tzioras, M., Davies, C., Newman, A., Jackson, R.J., & Spires‐Jones, T.L. (2018). Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease. <em>Neuropathology and Applied Neurobiology</em>. https://doi.org/10.1111/nan.12529
Vancouver
Tzioras M, Davies C, Newman A, Jackson RJ, Spires‐Jones TL. Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease. Neuropathology and Applied Neurobiology. 2018. doi:10.1111/nan.12529.
BibTeX
@article{makis2018Invite,
title = {Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease},
author = {Makis Tzioras and C. Davies and A. Newman and Rosemary J. Jackson and Tara L. Spires‐Jones},
journal = {Neuropathology and Applied Neurobiology},
year = {2018},
doi = {10.1111/nan.12529},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
NeuroImage 2022
Open access · CC-BY
Investigating the temporal pattern of neuroimaging-based brain age estimation as a biomarker for Alzheimer's Disease related neurodegeneration
Alzheimer s & Dementia 2021
Citation only
Cognitive correlations with amyloid, tau and neurodegeneration PET across the Alzheimer’s disease age spectrum
bioRxiv (Cold Spring Harbor Laboratory) 2023
Preprint · CC-BY
β-hydroxybutyrate is a metabolic regulator of proteostasis in the aged and Alzheimer disease brain
Annals of Neurology 2022
Open access · CC-BY
Microglial Activation and Connectivity in Alzheimer Disease and Aging
Current Alzheimer Research 2019
Citation only
Biomarkers for Alzheimer’s Disease
Innovation in Aging 2024
Open access · CC-BY